• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术后持续处方阿片类药物使用的床边风险评估的制定和验证。

Development and Validation of a Bedside Risk Assessment for Sustained Prescription Opioid Use After Surgery.

机构信息

Center for Surgery and Public Health, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Center for Surgery and Public Health, Division of Urology, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

出版信息

JAMA Netw Open. 2019 Jul 3;2(7):e196673. doi: 10.1001/jamanetworkopen.2019.6673.

DOI:10.1001/jamanetworkopen.2019.6673
PMID:31290987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6624809/
Abstract

IMPORTANCE

The increased use of prescription opioid medications has contributed to an epidemic of sustained opioid use, misuse, and addiction. Adults of working age are thought to be at greatest risk for prescription opioid dependence.

OBJECTIVE

To develop a risk score (the Stopping Opioids After Surgery score) for sustained prescription opioid use after surgery in a working-age population using readily available clinical information.

DESIGN, SETTING, AND PARTICIPANTS: In this case-control study, claims from TRICARE (the insurance program of the US Department of Defense) for working-age adult (age 18-64 years) patients undergoing 1 of 10 common surgical procedures from October 1, 2005, to September 30, 2014, were queried. A logistic regression model was used to identify variables associated with sustained prescription opioid use. The point estimate for each variable in the risk score was determined by its β coefficient in the model. The risk score for each patient represented the summed point totals, ranging from 0 to 100, with a lower score indicating lower risk of sustained prescription opioid use. Data were analyzed from September 25, 2018, to February 5, 2019.

EXPOSURES

Exposures were age; race; sex; marital status; socioeconomic status; discharge disposition; procedure intensity; length of stay; intensive care unit admission; comorbid diabetes, liver disease, renal disease, malignancy, depression, or anxiety; and prior opioid use status.

MAIN OUTCOMES AND MEASURES

The primary outcome was sustained prescription opioid use, defined as uninterrupted use for 6 months following surgery. A risk score for each patient was calculated and then used as a predictor of sustained opioid use after surgical intervention. The area under the curve and the Brier score were used to determine the accuracy of the scoring system and the Hosmer-Lemeshow goodness-of-fit test was used to evaluate model calibration.

RESULTS

Of 86 356 patients in the analysis (48 827 [56.5%] male; mean [SD] age, 46.5 [14.5] years), 6365 (7.4%) met criteria for sustained prescription opioid use. The sample used for model generation consisted of 64 767 patients, while the validation sample had 21 589 patients. Prior opioid exposure was the factor most strongly associated with sustained opioid use (odds ratio, 13.00; 95% CI, 11.87-14.23). The group with the lowest scores (<31) had a mean (SD) 4.1% (2.5%) risk of sustained opioid use; those with intermediate scores (31-50) had a mean (SD) risk of 14.9% (6.3%); and those with the highest scores (>50) had a mean (SD) risk of 35.8% (3.6%).

CONCLUSIONS AND RELEVANCE

This study developed an intuitive and accessible opioid risk assessment applicable to the care of working-age patients following surgery. This tool is scalable to clinical practice and can potentially be incorporated into electronic medical record platforms to enable automated calculation and clinical alerts that are generated in real time.

摘要

重要性

处方类阿片类药物使用的增加导致了持续使用阿片类药物、滥用和成瘾的流行。处于工作年龄的成年人被认为是处方类阿片类药物依赖的最大风险人群。

目的

利用易于获得的临床信息,为工作年龄人群在手术后持续使用处方类阿片类药物开发一个风险评分(术后手术持续使用阿片类药物评分)。

设计、地点和参与者:在这项病例对照研究中,查询了 2005 年 10 月 1 日至 2014 年 9 月 30 日期间接受 10 项常见手术之一的美国国防部医疗保险计划(TRICARE)的工作年龄(18-64 岁)成年患者的索赔信息。使用逻辑回归模型确定与持续使用处方类阿片类药物相关的变量。风险评分中每个变量的点估计值由其在模型中的β系数确定。每个患者的风险评分代表总积分,范围为 0 到 100,得分越低表示持续使用处方类阿片类药物的风险越低。数据分析于 2018 年 9 月 25 日至 2019 年 2 月 5 日进行。

暴露因素

年龄;种族;性别;婚姻状况;社会经济地位;出院情况;手术强度;住院时间;入住重症监护病房;合并糖尿病、肝脏疾病、肾脏疾病、恶性肿瘤、抑郁或焦虑;以及先前使用阿片类药物的情况。

主要结果和措施

主要结果是持续使用处方类阿片类药物,定义为手术后 6 个月内不间断使用。为每位患者计算了一个风险评分,并将其用作手术干预后持续使用阿片类药物的预测因子。曲线下面积和 Brier 评分用于确定评分系统的准确性,Hosmer-Lemeshow 拟合优度检验用于评估模型校准。

结果

在分析中,86356 名患者(48827[56.5%]名男性;平均[SD]年龄,46.5[14.5]岁)中,有 6365 名(7.4%)符合持续使用处方类阿片类药物的标准。用于模型生成的样本包括 64767 名患者,而验证样本有 21589 名患者。先前使用阿片类药物是与持续使用阿片类药物最密切相关的因素(比值比,13.00;95%CI,11.87-14.23)。分数最低(<31)的组持续使用阿片类药物的平均(SD)风险为 4.1%(2.5%);分数中等(31-50)的组平均(SD)风险为 14.9%(6.3%);分数最高(>50)的组平均(SD)风险为 35.8%(3.6%)。

结论和相关性

这项研究开发了一种直观且易于使用的阿片类药物风险评估方法,适用于手术后工作年龄患者的护理。该工具可扩展到临床实践中,并可潜在地整合到电子病历平台中,以实现实时自动计算和临床警报。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/639b/6624809/5a704c59eb6a/jamanetwopen-2-e196673-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/639b/6624809/5a704c59eb6a/jamanetwopen-2-e196673-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/639b/6624809/5a704c59eb6a/jamanetwopen-2-e196673-g001.jpg

相似文献

1
Development and Validation of a Bedside Risk Assessment for Sustained Prescription Opioid Use After Surgery.术后持续处方阿片类药物使用的床边风险评估的制定和验证。
JAMA Netw Open. 2019 Jul 3;2(7):e196673. doi: 10.1001/jamanetworkopen.2019.6673.
2
Association of Lowering Default Pill Counts in Electronic Medical Record Systems With Postoperative Opioid Prescribing.电子病历系统中降低默认药丸计数与术后阿片类药物处方之间的关联。
JAMA Surg. 2018 Nov 1;153(11):1012-1019. doi: 10.1001/jamasurg.2018.2083.
3
Machine learning for prediction of sustained opioid prescription after anterior cervical discectomy and fusion.机器学习在前路颈椎间盘切除融合术后预测持续阿片类药物处方
Spine J. 2019 Jun;19(6):976-983. doi: 10.1016/j.spinee.2019.01.009. Epub 2019 Jan 30.
4
Multimodal Local Opioid Prescribing Intervention Outcomes in Chronic Noncancer Pain Management.多模式局部阿片类药物处方干预在慢性非癌性疼痛管理中的效果。
J Am Board Fam Med. 2019 Jul-Aug;32(4):559-566. doi: 10.3122/jabfm.2019.04.180296.
5
Association of Hydrocodone Schedule Change With Opioid Prescriptions Following Surgery.氢可酮给药途径改变与术后阿片类药物处方的关联。
JAMA Surg. 2018 Dec 1;153(12):1111-1119. doi: 10.1001/jamasurg.2018.2651.
6
Association of the Use of a Mandatory Prescription Drug Monitoring Program With Prescribing Practices for Patients Undergoing Elective Surgery.强制性处方药物监测计划的使用与择期手术患者的处方实践之间的关联。
JAMA Surg. 2018 Dec 1;153(12):1105-1110. doi: 10.1001/jamasurg.2018.2666.
7
Opioid Prescribing and Use Patterns in Postsurgical Facial Trauma Patients.术后面部创伤患者的阿片类药物处方和使用模式。
Plast Reconstr Surg. 2020 Mar;145(3):780-789. doi: 10.1097/PRS.0000000000006588.
8
Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.受控物质处方模式 - 处方行为监测系统,八个州,2013 年。
MMWR Surveill Summ. 2015 Oct 16;64(9):1-14. doi: 10.15585/mmwr.ss6409a1.
9
No refills: The durable impact of a multifaceted effort by surgical trainees to minimize the prescription of postoperative opioids.无续方:外科受训者多方努力以尽量减少开具术后阿片类药物处方的持久影响。
Surgery. 2019 Nov;166(5):758-763. doi: 10.1016/j.surg.2019.05.021. Epub 2019 Jun 26.
10
Validating the Stopping Opioids after Surgery (SOS) score for sustained postoperative prescription opioid use in spine surgical patients.验证术后停止使用阿片类药物(SOS)评分在脊柱手术患者中持续术后处方阿片类药物使用的适用性。
Spine J. 2019 Oct;19(10):1666-1671. doi: 10.1016/j.spinee.2019.05.001. Epub 2019 May 9.

引用本文的文献

1
Prescription opioid use and substance use disorder in US women (2006-2022): a retrospective cohort study.美国女性的处方阿片类药物使用与物质使用障碍(2006 - 2022年):一项回顾性队列研究
Lancet Reg Health Am. 2025 Apr 18;46:101108. doi: 10.1016/j.lana.2025.101108. eCollection 2025 Jun.
2
Does Socioeconomic Status or Methamphetamine Use Affect Discharge Opioid Requirements in Burn-Injured Patients?社会经济地位或甲基苯丙胺使用会影响烧伤患者出院时的阿片类药物需求吗?
J Burn Care Res. 2022 May 17;43(3):534-540. doi: 10.1093/jbcr/irac009.
3
A Review of Leveraging Artificial Intelligence to Predict Persistent Postoperative Opioid Use and Opioid Use Disorder and its Ethical Considerations.

本文引用的文献

1
Prior Prescription Opioid Use and Its Influence on Opioid Requirements After Orthopedic Trauma.骨科创伤后先前阿片类药物使用及其对阿片类药物需求的影响。
J Surg Res. 2019 Jun;238:29-34. doi: 10.1016/j.jss.2019.01.016. Epub 2019 Feb 5.
2
Classifying Preoperative Opioid Use for Surgical Care.分类手术治疗前的阿片类药物使用情况。
Ann Surg. 2020 Jun;271(6):1080-1086. doi: 10.1097/SLA.0000000000003109.
3
Association of Opioid Prescribing With Opioid Consumption After Surgery in Michigan.密歇根州手术后阿片类药物处方与阿片类药物使用的关联。
利用人工智能预测术后持续使用阿片类药物和阿片类药物使用障碍及其伦理考量的综述
Curr Pain Headache Rep. 2025 Jan 23;29(1):30. doi: 10.1007/s11916-024-01319-2.
4
Long-term prescription opioid use following surgery in the US (2017-2022): a population-based study.美国术后长期使用处方阿片类药物情况(2017 - 2022年):一项基于人群的研究
Lancet Reg Health Am. 2024 Dec 4;40:100948. doi: 10.1016/j.lana.2024.100948. eCollection 2024 Dec.
5
Development of Chronic Pain Conditions Among Women in the Military Health System.女性在军医保健系统中慢性疼痛状况的发展。
JAMA Netw Open. 2024 Jul 1;7(7):e2420393. doi: 10.1001/jamanetworkopen.2024.20393.
6
Healthcare utilization and readiness outcomes among soldiers with post-deployment at-risk drinking, by multimorbidity class.士兵部署后有风险的饮酒行为与多重疾病类别之间的医疗保健利用和准备结果。
Alcohol. 2024 Feb;114:31-39. doi: 10.1016/j.alcohol.2023.08.008. Epub 2023 Aug 22.
7
Mu Opioid Receptor-Positive Neurons in the Dorsal Raphe Nucleus Are Impaired by Morphine Abstinence.背缝核中的μ阿片受体阳性神经元被吗啡戒断所损伤。
Biol Psychiatry. 2023 Dec 1;94(11):852-862. doi: 10.1016/j.biopsych.2023.06.024. Epub 2023 Jun 29.
8
Acute Pain and Development of Opioid Use Disorder: Patient Risk Factors.急性疼痛与阿片类药物使用障碍的发展:患者风险因素。
Curr Pain Headache Rep. 2023 Sep;27(9):437-444. doi: 10.1007/s11916-023-01127-0. Epub 2023 Jul 1.
9
Opioid prescribing and use in the Military Health System: a framework synthesis, FY2016-FY2021.军人健康系统中的阿片类药物处方和使用:2016 财年至 2021 财年的框架综合报告。
Pain Med. 2023 Oct 3;24(10):1133-1137. doi: 10.1093/pm/pnad072.
10
Diversity in U.S. Military Families: An Environmental Scan of the Peer-Reviewed Literature on Race and Ethnic Variation for Select Well-Being Outcomes.美国军人家庭的多样性:对关于种族和族裔差异与特定幸福成果的同行评审文献的环境审视。
Rand Health Q. 2023 May 15;10(2):7. eCollection 2023 May.
JAMA Surg. 2019 Jan 1;154(1):e184234. doi: 10.1001/jamasurg.2018.4234. Epub 2019 Jan 16.
4
Sustained Preoperative Opioid Use Is a Predictor of Continued Use Following Spine Surgery.术前持续使用阿片类药物是脊柱手术后继续使用的预测因素。
J Bone Joint Surg Am. 2018 Jun 6;100(11):914-921. doi: 10.2106/JBJS.17.00862.
5
Practical Guide to Surgical Data Sets: Military Health System Tricare Encounter Data.手术数据集实用指南:军事医疗系统的Tricare就诊数据
JAMA Surg. 2018 Jul 1;153(7):679-680. doi: 10.1001/jamasurg.2018.0480.
6
Leading the Way to Solutions to the Opioid Epidemic: AOA Critical Issues.引领阿片类药物流行解决方案之路:美国骨科医师学会关键问题。
J Bone Joint Surg Am. 2017 Nov 1;99(21):e113. doi: 10.2106/JBJS.17.00066.
7
Defining Optimal Length of Opioid Pain Medication Prescription After Common Surgical Procedures.定义常见手术后阿片类药物疼痛管理的最佳处方长度。
JAMA Surg. 2018 Jan 1;153(1):37-43. doi: 10.1001/jamasurg.2017.3132.
8
Sustained Prescription Opioid Use Among Previously Opioid-Naive Patients Insured Through TRICARE (2006-2014).TRICARE 保险的既往阿片类药物未使用者中持续处方类阿片类药物使用情况(2006-2014 年)。
JAMA Surg. 2017 Dec 1;152(12):1175-1176. doi: 10.1001/jamasurg.2017.2628.
9
Probability of Opioid Prescription Refilling After Surgery: Does Initial Prescription Dose Matter?手术后阿片类药物处方续用的可能性:初始处方剂量是否重要?
Ann Surg. 2018 Aug;268(2):271-276. doi: 10.1097/SLA.0000000000002308.
10
Preoperative Opiate Use Independently Predicts Narcotic Consumption and Complications After Total Joint Arthroplasty.术前使用阿片类药物可独立预测全关节置换术后的麻醉药物消耗量及并发症。
J Arthroplasty. 2017 Sep;32(9):2658-2662. doi: 10.1016/j.arth.2017.04.002. Epub 2017 Apr 12.